SG3 Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,000
| Closed | -$181K | – | 123 |
|
|
2022
Q4 | $181K | Buy |
+4,000
| New | +$181K | 0.03% | 38 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 285 |
|
|
2022
Q2 | – | Sell |
-10,000
| Closed | -$822K | – | 536 |
|
|
2022
Q1 | $822K | Buy |
10,000
+4,500
| +82% | +$370K | 0.02% | 74 |
|
|
2021
Q4 | $807K | Sell |
5,500
-8,500
| -61% | -$1.25M | 0.02% | 104 |
|
|
2021
Q3 | $2.48M | Buy |
+14,000
| New | +$2.48M | 0.08% | 23 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 776 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 830 |
|
|
2020
Q4 | – | Sell |
-2,000
| Closed | -$332K | – | 682 |
|
|
2020
Q3 | $332K | Sell |
2,000
-5,500
| -73% | -$913K | 0.01% | 129 |
|
|
2020
Q2 | $856K | Buy |
7,500
+2,000
| +36% | +$228K | 0.06% | 49 |
|
|
2020
Q1 | $423K | Buy |
+5,500
| New | +$423K | 0.06% | 30 |
|